Hematology, Hemostasis, & Urinalysis
|5 min read
The Power of Vendor–Laboratory Partnerships
Geisinger Medical Center’s immunology laboratory recently maximized their workflows through a vital partnership with Thermo Fisher Scientific
|2 min read
FDA Approves Recombinant Enzyme to Treat Rare Blood Clotting Disorder
Adzynma safely and effectively “filled in” for the mutated ADAMTS13 enzyme in patients with cTTP
|4 min read
Insulin Resistance and Cardiometabolic Health
Michael McPhaul, MD, discusses advances in insulin resistance testing
|2 min read
Mpox Virus Continues to Evolve through Human Transmission
Several mutations in mpox prove that the virus sustained human-to-human transmission, not just zoonotic spillover
|3 min read
FDA Approves New Therapeutic for Myelodysplastic Syndromes
Tibsovo can be used with FDA-approved companion diagnostic RealTime IDH1 Assay to detect and treat MDS
|3 min read
CAR T-Cell Therapy Shows Race-Agnostic Response in MM Patients
Multiple myeloma patients treated with CAR T-cell therapy showed similar survival outcomes regardless of race or ethnicity
|3 min read
Gene Therapy for Glioblastoma Shows Promise in Phase 1 Trial
In a first-in-human trial in patients with recurrent glioblastoma, an oncolytic virus treatment safely extended survival
|2 min read
Live Vaccines Could Be Safe for Pediatric Transplant Recipients
Recent trial findings suggest live vaccines could protect more immunocompromised children from infectious diseases
|2 min read
New Transfusion Guidelines Recommend Assessing Patient Comorbidities
The expert panel developed recommendations to conserve blood supply and prevent transfusion-related illnesses
|2 min read
Small-Volume Blood Draws Could Cut Down Transfusions
The large trial showed switching to smaller collection tubes saved almost one blood transfusion for every 10 patients
|2 min read
Toxic, Ultrashort PFAS Detected in Water, Serum, Urine
Studies suggest that shorter PFAS may easily find their way into homes and are more toxic than PFOS and PFOA
|3 min read
